Common Cold

110 registered clinical trials studyying Common Cold — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Post-market Clinical Follow-up Study of an Isotonic Saline Solution to Manage Nasal Congestion in Case of Flu NCT07257224	Laboratoires Quinton International S.L.	—
Active Not Recruiting	A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Throat Spray on the Incidenc NCT07246850	Beekeeper's Naturals Inc	N/A
Completed	A Clinical Evidence Study Evaluating Quality of Life Parameters Following Treatment With Robitussin NCT06716645	HALEON	Phase 4
Withdrawn	Efficacy and Safety of the Combination of Acetylcysteine, Paracetamol and Phenylephrine for the Treatment of C NCT05070650	Sandoz	Phase 3
Completed	Efficacy and Safety of Silfamin for Common Cold NCT06497439	Dexa Medica Group	Phase 2
Recruiting	Effects of LP28 on Immunity Enhancement in the Elderly NCT06724185	Synbio Tech Inc.	N/A
Recruiting	Efficacy and Safety in the Combination of Ibuprofen / Loratadine Versus Ibuprofen Versus Loratadine NCT06531707	Laboratorios Silanes S.A. de C.V.	Phase 3
Completed	Effectiveness of a Nasal Spray on Viral Respiratory Infections NCT06278324	CEN Biotech	N/A
Unknown	Efficacy and Safety of Ingavirin®, Capsules, 60 mg, in Children With Influenza and Other Acute Respiratory Vir NCT06315400	Valenta Pharm JSC	Phase 4
Recruiting	A Study of the Efficacy and Safety of Antiwei Granules in the Treatment of Common Cold NCT06697886	Tasly Pharmaceutical Group Co., Ltd	Phase 3
Unknown	Commercially Available Cannabis Products for Immune Support NCT05944705	Center For Interventional Pain and Spine	—
Completed	Supporting Parents to Choose Wisely NCT06005337	University of Alberta	N/A
Completed	Post Market Clinical Follow-Up Study - Medical Device KalobaNaso NCT05960318	Schwabe Pharma Italia	—
Completed	BАbykids Spray In Common Cold NCT05819203	Lallemand Pharma AG	N/A
Completed	Testing the Efficacy in Adults With Cold of HEalsea Rescue* NCT05819190	Lallemand Pharma AG	N/A
Completed	Otrivine: Quality of Life (QoL) Impact in a Real-World Setting NCT05556148	HALEON	Phase 4
Completed	Alleviation of Common Cold Symptoms NCT06106880	Applied Biological Laboratories Inc	Phase 1
Completed	Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute NCT05273619	Valenta Pharm JSC	Phase 3
Completed	The Preventive Effectiveness of the Individualized Jade Wind-Barrier Herbal Tea Bag on the Common Cold in Elde NCT05640570	Hong Kong Baptist University	Phase 2
Completed	Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK) NCT05034328	Lallemand Pharma AG	—
Completed	A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous Usage NCT05126407	Johnson & Johnson Consumer Inc. (J&JCI)	—
Terminated	Two Seawater-based Formulations for Relief of Nasal Congestion in Paediatric Subjects NCT05244148	Church & Dwight Company, Inc.	N/A
Completed	Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory V NCT05269290	Valenta Pharm JSC	Phase 3
Completed	Study to Evaluate the Efficacy of EZC Pak in Adults With Upper Respiratory Infection (URI) NCT04943575	PPC Pharmaceuticals	N/A
Completed	Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute NCT05269329	Valenta Pharm JSC	Phase 2
Unknown	The Effect of Probiotic and Zinc Supplementation on the Common Cold NCT04672850	Lund University	N/A
Completed	Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care NCT04681001	Marinomed Biotech AG	N/A
Completed	Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus In NCT05002179	A. Vogel AG	Phase 4
Completed	Study to Investigate if Sucking a Coldamaris Lozenge Elutes Sufficient Iota-carrageenan to Inactivate Usual Co NCT04533906	Marinomed Biotech AG	N/A
Completed	Audio Data Collection for Identification and Classification of Coughing NCT04326309	HealthMode Inc.	—
Withdrawn	Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection NCT04368520	Queen Mary University of London	Phase 2
Unknown	Herbal Medicine 'Eungyosan' and 'Samsoeum' for Common Cold NCT04073511	Korean Medicine Hospital of Pusan National University	N/A
Completed	Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda NCT04144491	VU University of Amsterdam	N/A
Withdrawn	Efficacy and Safety of Irlanda-1-Association on the Treatment of Common Cold in Children NCT02656888	EMS	Phase 3
Withdrawn	Efficacy and Safety of Irlanda-2 Association on the Treatment of Common Cold NCT02656914	EMS	Phase 3
Completed	Duration of ColdZyme® II NCT03901846	Enzymatica AB	N/A
Completed	Double-blind, Randomized, Parallel-group, Placebo-controlled Study to Evaluate Efficacy of CMS008618 for Commo NCT03794804	Enzymatica AB	N/A
Completed	Digital Online Consultations - Effects on Antibiotic Prescribing and Health Care Utilization in Primary Care NCT03474887	Region Skane	—
Completed	To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers NCT03415243	GlaxoSmithKline	Phase 1
Completed	Evaluation of the Use of Various Assessments of Common Cold Symptoms for Proof of Efficacy of ColdZyme Mouth S NCT03831763	Enzymatica AB	N/A
Completed	The Effect of Zinc Acetate Lozenges on the Rate of Recovery From the Common Cold NCT03309995	University of Helsinki	N/A
Terminated	Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the NCT03339726	Johnson & Johnson Consumer Inc. (J&JCI)	Phase 2
Completed	PEACe: Ivy, Thyme and Cisti Extract (Phytus) Efficacy in Acute Cough NCT02981147	PharmEvo Pvt Ltd	Phase 4
Withdrawn	Echinaforce Junior Bioavailability Trial NCT03070314	A. Vogel AG	Phase 4
Completed	To Evaluate the Efficacy and Safety of 1146A Nasal Spray in Adult Participants With Symptoms of Common Cold NCT03005067	GlaxoSmithKline	Phase 2
Completed	Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department NCT02957136	University of California, Davis	N/A
Completed	Local Nasal Tolerability and Safety Study of 1146A in Healthy Adult Participants NCT02832362	GlaxoSmithKline	Phase 1
Withdrawn	Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Co NCT01938144	Pfizer	Phase 3
Completed	Evaluation of ColdZyme® on Experimentally Induced Common Cold. NCT02479750	Enzymatica AB	N/A
Completed	Effect of Probiotic on Rhinovirus Induced Colds NCT02679807	University of Virginia	N/A
Completed	Warming Sensation and Tolerability Study of Acetylcysteine 2% Oral Solution for Productive Cough NCT02822287	GlaxoSmithKline	Phase 3
Completed	Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Pat NCT02644018	Valenta Pharm JSC	Phase 3
Completed	Efficacy and Safety of Resveratrol and Carbossimetyl Beta Glucan in Treatment of Upper Airways Disease in Infa NCT03683108	Policlinico Hospital	Phase 3
Completed	Nasal Swab Study to Explore the Nasal Microbia NCT02535442	Kimberly-Clark Corporation	—
Completed	Effect of OC459 on the Response to Rhinovirus Challenge in Asthma NCT02660489	Imperial College London	Phase 2
Completed	The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine M NCT02246166	GlaxoSmithKline	Phase 4
Completed	DBRCT on the Effect of Wheat Polysaccharides on Common Cold Infections in Elderly NCT02451163	Clinical Research Center Kiel GmbH	Phase 2
Completed	Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children NCT03191097	Valenta Pharm JSC	Phase 3
Completed	Hypertonic Saline Nasal Irrigation and Gargling for the Common Cold. NCT02438579	NHS Lothian	N/A
Completed	Safety and Intake Effect of EPs® 7630 (an Extract of the Roots of Pelargonium Sidoides) NCT02174653	Dr. Willmar Schwabe GmbH & Co. KG	Phase 3
Terminated	Benefit and Tolerability of IQP-AS-105 in Reducing Susceptibility to Upper Respiratory Tract Infections NCT01964885	InQpharm Group	Phase 3
Completed	Iota-Carrageenan Nasal Spray in Common Cold NCT01944631	Boehringer Ingelheim	Phase 4
Completed	Evaluation of ColdZyme® Mouth Spray on Prevention and Alleviation of Rhinovirus Induced Common Cold NCT02522949	Enzymatica AB	N/A
Completed	A Study of Nasal Glucagon in Participants With a Common Cold NCT02778100	Eli Lilly and Company	Phase 1
Completed	Experimental Human Rhinovirus Infection NCT01823640	Radboud University Medical Center	Phase 1
Completed	Glucose Oxidase as Treatment Against Common Cold NCT01883440	Krister Tano	Phase 2
Completed	A Nasal Spray With Glucose Oxidase as a Treatment of Common Cold NCT01883453	Umeå University	Phase 2
Completed	Efficacy and Safety Study of Homeopathic Oral Antibodies to Treat Viral Upper Respiratory Tract Infections NCT01651715	Theranor s.p.r.l	Phase 1 / Phase 2
Completed	Effect of Probiotic on the Innate and Adaptive Host Response to Rhinovirus (EPIARR) NCT01669603	University of Virginia	N/A
Completed	A Study of an Experimental Nasal Spray in Subjects With Early Signs of the Common Cold NCT01488604	McNeil AB	N/A
Completed	Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Patients NCT03206346	Valenta Pharm JSC	Phase 3
Completed	A Double-blind, Randomised, Parallel Group,Comparative Study With Rose-hip Liquid and Placebo Given to Healthy NCT01459952	Hyben Vital ApS	Phase 3
Completed	Effects of Two Doses of a Common Cold Treatment on Alertness NCT01686646	GlaxoSmithKline	Phase 3
Completed	Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive System NCT01677715	Inner Mongolia Yili Industrial Group Co., Ltd	N/A
Completed	A Comparison of Solid and Soluble Forms of Cold and Influenza Remedies NCT01332578	GlaxoSmithKline	Phase 4
Completed	Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human Immunization NCT01677702	Inner Mongolia Yili Industrial Group Co., Ltd	N/A
Completed	Effects of a Common Cold Treatment on Cognitive Function NCT01466348	GlaxoSmithKline	Phase 4
Terminated	Acute Cough Study In Children NCT01257542	Pfizer	Phase 4
Completed	Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections NCT03189537	Valenta Pharm JSC	Phase 3
Completed	Effect of Paracetamol on the Common Cold NCT01277081	GlaxoSmithKline	Phase 2
Completed	Evaluation of Efficacy and Safety of Oral Solution Resfenol in Reducing Symptoms of Common Cold And Flu NCT01158326	Hospital de Clinicas de Porto Alegre	Phase 3
Completed	Safety and Efficacy Study of Oral XIGO Tablets to Treat The Common Cold NCT01092039	Xigo Health LLC	N/A
Completed	Efficacy and Safety Study of Ingavirin® 90 mg Once Daily to Treat Influenza and Other Acute Viral Infections i NCT03154515	Valenta Pharm JSC	Phase 4
Completed	Mucinex Exploratory Cold Study NCT01046136	Reckitt Benckiser Inc.	Phase 2
Completed	Effectiveness of a Handwashing Programme in the Prevention of School Absenteeism Due to Respiratory Infections NCT01728090	Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental	Phase 4
Completed	Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold NCT00963443	Bayer	Phase 3
Unknown	Efficacy Study of A Lotion to Prevent Common Colds NCT00993759	The Dial Corporation	Phase 2
Unknown	Efficacy and Safety Assessment of an Anti-Cold Preparation in the Symptomatic Treatment of Common Cold and Flu NCT00940836	Hospital de Clinicas de Porto Alegre	Phase 3
Completed	Encapsulated Juice Powder Concentrate for Preventing Common Cold Symptoms NCT00778648	Charite University, Berlin, Germany	N/A
Completed	Efficacy Trial of 3804-250A in the Prevention of Cold Illnesses NCT00762476	The Dial Corporation	Phase 2
Completed	Trial to Evaluate the Use of Pomegranate Concentrate (POMx) for the Prevention of Experimental Rhinovirus Infe NCT00655031	POM Wonderful LLC	Phase 2
Completed	Effectiveness of Local Application of Warm Air in Patients With Common Cold (HELI Study) NCT00552981	Charite University, Berlin, Germany	N/A
Completed	Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects NCT00452270	Novartis	Phase 3
Completed	Efficacy and Safety of Sinutab on Subjects in the Setting of a Common Cold NCT00378144	McNeil AB	Phase 4
Completed	Pomegranate Products for Prevention of Common Cold NCT00617318	Texas Heart Institute	Phase 3
Completed	Evaluation of Safety of ZyComb® In Patients With Common Cold - ZIP 3000 (XY-005-IM) NCT00480194	Nycomed	—
Completed	Stopping Upper Respiratory Infections and Flu in the Family: The Stuffy Trial NCT00448981	Centers for Disease Control and Prevention	N/A
Completed	The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years NCT00405509	West Penn Allegheny Health System	—
Completed	Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposu NCT00394914	Merck Sharp & Dohme LLC	Phase 2
Completed	Kinetics of Etheric Oils, Smart Textiles vs. Ointment NCT00299559	Technische Universität Dresden	Phase 1
Completed	Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers NCT00231218	The Cleveland Clinic	Phase 3
Completed	Placebo and Active Controlled Study to Assess Efficacy and Tolerability of Aspirin Plus Pseudoephedrine NCT01062360	Bayer	Phase 3
Completed	Symptomatic Treatment of Common Cold Symptoms NCT01033526	Bayer	Phase 4
Completed	Active and Placebo Controlled Study to Test the Efficacy and Safety of an Aspirin-Lidocaine Lozenge in the Sym NCT01361399	Bayer	Phase 3
Completed	Placebo and Active Controlled Study to Compare the Efficacy of Aspirin and Paracetamol in Treatment of Sore Th NCT01465009	Bayer	Phase 4
Completed	Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo) NCT00065715	University of Wisconsin, Madison	Phase 3
Completed	Evaluation of Echinacea for the Common Cold NCT00032500	National Center for Complementary and Integrative Health (NCCIH)	Phase 2
Completed	Efficacy of Homeopathic Nasal Formulation for Management of Experimental Rhinoviral Colds NCT00358774	University of Wisconsin, Madison	Phase 1 / Phase 2
Completed	A Trial of Echinacea in Children NCT00029211	National Center for Complementary and Integrative Health (NCCIH)	Phase 3
Withdrawn	Study Comparing 3 Formulations to Evaluate the Efficacy and Safety of the Inflammatory Symptoms of the Upper R NCT00967759	Ache Laboratorios Farmaceuticos S.A.	Phase 3